Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia

Among patients with schizophrenia, LAI use is associated with an approximately 30% lower risk of death compared with oral agents. SG LAIs and oral aripiprazole are associated with the lowest mortality.